TY - STD TI - World Health Organization. HIV drug resistance report 2017. Geneva: World Health Organization. 2017. Licence: CC BY-NC-SA 3.0 IGO. ID - ref1 ER - TY - CHAP AU - Mbuagbaw, L. AU - Aves, T. AU - Borhan, S. AU - Leenus, A. AU - Jordan, M. J. AU - Parkin, N. PY - 2017 DA - 2017// TI - Systematic reviews and meta-analyses used to inform the World health Organization Guidelines on the public health response to pre-treatment HIV drug resistance. 2017. [Publication pending]. Web Annex 2 BT - Guidelines on the public health response to pre-treatment HIV drug resistance PB - World health Organization CY - Geneva ID - Mbuagbaw2017 ER - TY - CHAP PY - 2016 DA - 2016// TI - Consolidated guidelines on the use of antiretroviral drugs for treating and prevent HIV infection: recommendations for a public health approach BT - Second edition ID - ref3 ER - TY - JOUR AU - Prosperi, M. C. AU - Mackie, N. AU - Giambenedetto, S. AU - Zazzi, M. AU - Camacho, R. AU - Fanti, I. PY - 2011 DA - 2011// TI - Detection of drug resistance mutations at low plasma HIV-1 RNA load in a European multicentre cohort study JO - J Antimicrob Chemother VL - 66 UR - https://doi.org/10.1093/jac/dkr171 DO - 10.1093/jac/dkr171 ID - Prosperi2011 ER - TY - JOUR AU - Pham, Q. D. AU - Wilson, D. P. AU - Nguyen, T. V. AU - Do, N. T. AU - Truong, L. X. AU - Nguyen, L. T. PY - 2016 DA - 2016// TI - Projecting the epidemiological effect, cost-effectiveness and transmission of HIV drug resistance in Vietnam associated with viral load monitoring strategies JO - J Antimicrob Chemother VL - 71 UR - https://doi.org/10.1093/jac/dkv473 DO - 10.1093/jac/dkv473 ID - Pham2016 ER - TY - JOUR AU - Luca, A. AU - Marazzi, M. C. AU - Mancinelli, S. AU - Ceffa, S. AU - Altan, A. M. AU - Buonomo, E. PY - 2012 DA - 2012// TI - Prognostic value of virological and immunological responses after 6 months of antiretroviral treatment in adults with HIV-1 infection in sub-Saharan Africa JO - J Acquir Immune Defic Syndr VL - 59 UR - https://doi.org/10.1097/QAI.0b013e31824276e9 DO - 10.1097/QAI.0b013e31824276e9 ID - Luca2012 ER - TY - JOUR AU - Rawizza, H. E. AU - Chaplin, B. AU - Meloni, S. T. AU - Eisen, G. AU - Rao, T. AU - Sankalè, J. L. PY - 2011 DA - 2011// TI - Immunologic criteria are poor predictors of virologic outcome: implications for HIV treatment monitoring in resource-limited settings JO - Clin Infect Dis VL - 53 UR - https://doi.org/10.1093/cid/cir729 DO - 10.1093/cid/cir729 ID - Rawizza2011 ER - TY - JOUR AU - Sigaloff, K. C. AU - Hamers, R. L. AU - Wallis, C. L. AU - Kityo, C. AU - Siwale, M. AU - Ive, P. PY - 2011 DA - 2011// TI - Unnecessary antiretroviral treatment switches and accumulation of HIV resistance mutations; two arguments for viral load monitoring in Africa JO - J Acquir Immune Defic Syndr VL - 58 UR - https://doi.org/10.1097/QAI.0b013e318227fc34 DO - 10.1097/QAI.0b013e318227fc34 ID - Sigaloff2011 ER - TY - JOUR AU - Ruperez, M. AU - Pou, C. AU - Macaluve, S. AU - Cedeno, S. AU - Luis, L. AU - Rodriguez, J. PY - 2015 DA - 2015// TI - Determinants of virological failure and antiretroviral drug resistance in Mozambique JO - J Antimicrob Chemother VL - 70 UR - https://doi.org/10.1093/jac/dkv143 DO - 10.1093/jac/dkv143 ID - Ruperez2015 ER - TY - STD TI - DREAM Community of Sant’Egidio. The goal of a dream. Achieving millenium development goals. http://dream.santegidio.org/wp-content/uploads/2015/01/DREAM_MDG_def.pdf. UR - http://dream.santegidio.org/wp-content/uploads/2015/01/DREAM_MDG_def.pdf ID - ref10 ER - TY - STD TI - UNAIDS.HIV and AIDS estimates. 2015. http://www.unaids.org/en/regionscountries/countries/mozambique/. UR - http://www.unaids.org/en/regionscountries/countries/mozambique/ ID - ref11 ER - TY - JOUR AU - Bila, D. C. A. AU - Boullosa, L. T. AU - Vubli, A. S. AU - Mabunda, N. J. AU - Abreu, C. M. AU - Ismael, N. PY - 2015 DA - 2015// TI - Trends in prevalence of HIV-1 drug resistance in a public clinic in Maputo, Mozambique JO - PLoS One VL - 10 UR - https://doi.org/10.1371/journal.pone.0130580 DO - 10.1371/journal.pone.0130580 ID - Bila2015 ER - TY - JOUR AU - Luca, A. AU - Hamers, R. L. AU - Shapiro, J. M. PY - 2013 DA - 2013// TI - Antiretroviral treatment sequencing strategies to overcome HIV type 1 drug resistance in adolescents and adults in low-middle-income countries JO - J Infect Dis VL - 207 UR - https://doi.org/10.1093/infdis/jit109 DO - 10.1093/infdis/jit109 ID - Luca2013 ER - TY - JOUR AU - Sigaloff, K. C. AU - Ramatsebe, T. AU - Viana, R. AU - Wilt, T. F. AU - Wallis, C. L. AU - Stevens, W. S. PY - 2012 DA - 2012// TI - Accumulation of HIV drug resistance mutations in patients failing first-line antiretroviral treatment in South Africa JO - AIDS Res Hum Retrovirus VL - 28 UR - https://doi.org/10.1089/aid.2011.0136 DO - 10.1089/aid.2011.0136 ID - Sigaloff2012 ER - TY - JOUR AU - Gupta, R. K. AU - Ford, D. AU - Mulenga, V. AU - Walker, A. S. AU - Kabamba, D. AU - Kalumbi, M. PY - 2010 DA - 2010// TI - Drug resistance in human immunodeficiency virus type-1 infected Zambian children using adult fixed dose combination stavudine, lamivudine, and nevirapine JO - Pediatr Infect Dis J VL - 29 UR - https://doi.org/10.1097/INF.0b013e3181e47609 DO - 10.1097/INF.0b013e3181e47609 ID - Gupta2010 ER - TY - JOUR AU - Goodall, R. L. AU - Dunn, D. T. AU - Nkurunziza, P. AU - Mugarura, L. AU - Pattery, T. AU - Munderi, P. PY - 2017 DA - 2017// TI - Rapid accumulation of HIV-1 thymidine analogue mutations and phenotypic impact following prolonged viral failure on zidovudine-based first-line ART in sub-Saharan Africa JO - J Antimicrob Chemother VL - 72 UR - https://doi.org/10.1093/jac/dkw583 DO - 10.1093/jac/dkw583 ID - Goodall2017 ER - TY - JOUR AU - Boender, T. S. AU - Kityo, C. M. AU - Boerma, R. S. AU - Hamers, R. L. AU - Ondoa, P. AU - Wellington, M. PY - 2016 DA - 2016// TI - Accumulation of HIV-1 drug resistance after continued virological failure on first-line ART in adults and children in sub-Saharan Africa JO - J Antimicrob Chemother VL - 71 UR - https://doi.org/10.1093/jac/dkw218 DO - 10.1093/jac/dkw218 ID - Boender2016 ER - TY - JOUR AU - Guichet, E. AU - Aghokeng, A. AU - Serrano, L. AU - Bado, G. AU - Toure-Kane, C. AU - Eymard-Duvernay, S. PY - 2016 DA - 2016// TI - Short Communication: High viral load and multidrug resistance due to late switch to second-line regimens could be a major obstacle to reach the 90-90-90 UNAIDS objectives in sub-Saharan Africa JO - AIDS Res Hum Retrovir VL - 32 UR - https://doi.org/10.1089/aid.2016.0010 DO - 10.1089/aid.2016.0010 ID - Guichet2016 ER - TY - JOUR AU - Brehm, J. H. AU - Koontz, D. L. AU - Wallis, C. L. AU - Shutt, K. A. AU - Sanne, I. AU - Wood, R. PY - 2012 DA - 2012// TI - Frequent emergence of N348I in HIV-1 subtype C reverse transcriptase with failure of initial therapy reduces susceptibility to reverse-transcriptase inhibitors JO - Clin Infect Dis VL - 55 UR - https://doi.org/10.1093/cid/cis501 DO - 10.1093/cid/cis501 ID - Brehm2012 ER - TY - JOUR AU - Sigaloff, K. C. AU - Hamers, R. L. AU - Wallis, C. L. AU - Kityo, C. AU - Siwale, M. AU - Ive, P. PY - 2012 DA - 2012// TI - Second-line antiretroviral treatment successfully resuppresses drug-resistant HIV-1 after first-line failure: prospective cohort in sub-Saharan Africa JO - J Infect Dis VL - 11 UR - https://doi.org/10.1093/infdis/jis261 DO - 10.1093/infdis/jis261 ID - Sigaloff2012 ER - TY - JOUR AU - Paton, N. I. AU - Kityo, C. AU - Thompson, J. AU - Nankya, I. AU - Bagenda, L. AU - Hoppe, A. PY - 2017 DA - 2017// TI - Nucleoside reverse-transcriptase inhibitor cross-resistance and outcomes from second-line antiretroviral therapy in the public health approach: an observational analysis within the randomised, open-label, EARNEST trial JO - Lancet HIV VL - 4 UR - https://doi.org/10.1016/S2352-3018(17)30065-6 DO - 10.1016/S2352-3018(17)30065-6 ID - Paton2017 ER - TY - JOUR AU - Boyd, M. A. AU - Moore, C. L. AU - Molina, J. M. AU - Wood, R. AU - Madero, J. S. AU - Wolff, M. PY - 2015 DA - 2015// TI - Baseline HIV-1 resistance, virological outcomes, and emergent resistance in the SECOND-LINE trial: an exploratory analysys JO - Lancet HIV VL - 2 UR - https://doi.org/10.1016/S2352-3018(14)00061-7 DO - 10.1016/S2352-3018(14)00061-7 ID - Boyd2015 ER -